Vetoquinol is ready to welcome you to the 2024 International Veterinary Emergency and Critical Care Society (IVECCS) Symposium. Stop by booth #504 to hear about our newest product and promotion!
📣 Mark your calendar for these cardiovascular and toxicology sessions sponsored by Vetoquinol at IVECCS. https://iveccs2024.mapyourshow.com/8_0/sessions/#/
1:30 p.m., Sat., Sept. 7: Why in the World Would They Eat That!? And What Should I Do Now? An Update on Common Toxins, Decontamination, and Treatment Options
2:45 p.m., Sat., Sept. 7: Top 5 Questions About Extracorporeal Therapy in Acute Intoxications
4 p.m., Sat., Sept. 7: Diagnostic Testing in the ER: What's Toxic, What's Not?
8 a.m., Wed., Sept. 11: Accessory Pathways: Why Every Clinician Should Care
9:15 a.m., Wed., Sept. 11: A Primer on Pressors
10:30 a.m., Wed., Sept. 11: What is this ECG? Diagnosis and Management of Arrhythmia for ER Docs
#IVECCS #IVECCS2024 #vetoquinol #veterinarymedicine
Veterinarians can now order UpCard®-CA1 (torsemide oral solution) through their preferred distributor or Vetoquinol Territory Manager. For full prescribing information, visit http://www.vetoquinolusa.com/upcard-ca1-info
UpCard-CA1 is conditionally approved by the FDA for use with concurrent therapy with pimobendan, spironolactone, and an angiotensin converting enzyme (ACE) inhibitor for the management of pulmonary edema in dogs with congestive heart failure caused by myxomatous mitral valve disease (MMVD).
We're in New Orleans this week for the 2024 National Business Meeting!
MAKING HISTORY! 🎉🎉🎉
Our dedication to sustainability, both in the present and for the future. 🌎